5-Amino-3,3-dimethylisobenzofuran-1(3H)-one, 97%, 1g

Methyl 3-bromo-2-(bromomethyl)propanoate, 95.0%, 5g

N-(2-chloroethyl)-4-methylbenzenesulfonamide, 250mg

(3-(Cyclohexylcarbamoyl)-5-fluorophenyl)boronic acid, 95.0%, 5g

1-Benzyl-4-oxoazepane hydrochloride, 97.0%, 500mg

4-((tert-Butoxycarbonyl)(methyl)amino)benzoic acid, 95.0%, 250mg

6-chloro-N~4~-ethylpyrimidine-2,4-diamine, 95.0%, 1g

Filtration unit Rapid-Flow with PES membrane Pore size 0.2 μm, 150 ml, 150 ml, 50 mm, 12 Piece(s)

2-Hexyn-1-ol, 95.0%, 5g

1-(tert-Butoxycarbonyl)-4-((5-fluoropyridin-2-yl)amino)piperidine-4-carboxylic acid, 97%, 250mg

6,7-DIMETHOXY-2-METHYL-4-(PIPERAZIN-1-YL)QUINAZOLINE, 95.0%, 250mg

Piperazine-2-carboxylic acid, 98.0%, 10g

TERT-BUTYL (1-(DIMETHYLCARBAMOYL)CYCLOPROPYL)(METHYL)CARBAMATE, 95.0%, 250mg